These anti-obesity effects also necessitated the presence of ErbB4, as ErbB4 deficiency led to severe inflammation, increased lipogenesis, and increased serum leptin levels (Zeng et al., 2018). This evidence concerns the gene ERBB4 and obesity disorder.